Author

Vitalij Woloschin

Heinrich Heine University Düsseldorf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Sanil BhatiaiD· 2 shared Thomas KurziD· 2 shared Andrea Kulik· 1 shared Annabelle Friedrich· 1 shared Arndt BorkhardtiD· 1 shared Beate Lungerich· 1 shared Björn StorkiD· 1 shared Céline David· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Sanil BhatiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyCell Death and DiseasePeer-reviewedDec 23, 2025

Small-molecule inhibitor of C-terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells

Céline David, Yadong Sun, Vitalij Woloschin…·Björn Stork

This paper introduces a C-terminal HSP90 dimerization inhibitor, VWK147, which induces cell death in cisplatin-resistant cancer cells and synergizes with mTOR inhibition to enhance therapeutic efficacy.

7 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 2, 2024

Development of a Bipyrimidineamide based α-Helix Mimetic Lead Compound for efficient Targeting of MDM2 in Triple-Negative Breast Cancer

Jasmin Linh On, Vitalij Woloschin, Franziska Gier…·Knud Esser

This study develops a bipyrimidineamide-based α-helix mimetic compound, VWK603, which effectively targets MDM2 in TNBC cells with lower toxicity than Nutlin-3a.

DOI 10.1101/2024.03.02.582899

humanexperimental assay

𝕏 PostBluesky